Back to search

Netherlands· NL-331240fce7be

Vyjuvek 5×10^9 plaquevormende eenheden/ml suspensie en gel voor gel

A beremagene geperpavec product containing beremageen geperpavec, registered in Netherlands by Krystal Biotech Netherlands B.V.. The same ATC class is registered in 9 of our 19 countries.

ATC D03AX16

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedVyjuvek 5×10^9 plaquevormende eenhede…ATCD03AX16REGISTER NO.NL-331240fce7bePACKS LISTED1CHECKEDSeptember 29, 2026

Where it is registered

Beremagene geperpavec is registered in 9 of 19 countries.

Countries holding a registration under ATC D03AX16 (beremagene geperpavec), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 6 of them publish a price we can compare per daily dose

Beremagene geperpavec · ATC D03AX16

9 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Polandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)
Active substance
BEREMAGEEN GEPERPAVEC
Manufacturer
Krystal Biotech Netherlands B.V.
Country
Netherlands (NL)
ATC code
D03AX16
ATC class
Beremagene geperpavec
Defined daily dose
0.14286 ml, T
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    EU/1/25/1918

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/180c6567-8546-496f-a267-2e5e013a63f4
GET /v1/drugs/180c6567-8546-496f-a267-2e5e013a63f4?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Gel",
  "route": "Cutaan gebruik",
  "soort": null,
  "source": "cbg_meb",
  "smpc_url": "https://www.ema.europa.eu/en/documents/product-information/vyjuvek-epar-product-information_nl.pdf",
  "strength": null,
  "atc_label": "Beremagene geperpavec",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp132535",
  "excipients": [
    "DINATRIUMWATERSTOFFOSFAAT 2-WATER (E 339)",
    "DINATRIUMWATERSTOFFOSFAAT 7-WATER (E 339)",
    "DINATRIUMWATERSTOFFOSFAAT 7-WATER (E 339)",
    "GLYCEROL (E 422)",
    "HYPROMELLOSE 2208, K100 (E 464)",
    "KALIUMCHLORIDE (E 508)",
    "KALIUMDIWATERSTOFFOSFAAT 0-WATER (E 340)",
    "KALIUMDIWATERSTOFFOSFAAT 0-WATER (E 340)",
    "NATRIUMCHLORIDE",
    "NATRIUMCHLORIDE",
    "TROMETAMOL",
    "WATER VOOR INJECTIE",
    "WATER VOOR INJECTIE"
  ],
  "substances": [
    "BEREMAGEEN GEPERPAVEC"
  ],
  "leaflet_url": null,
  "authorised_at": "2025/04/23",
  "procedure_number": "EMEA/H/C/006330",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "EU/1/25/1918",
  "additional_monitoring": "Y"
}

See everything about beremagene geperpavec.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.